Sept 17 (Reuters) - U.S. Food and Drug Administration:
* U.S. FDA SAYS ANNOUNCING PROJECT ORBIS, AN INITIATIVE OF THE FDA ONCOLOGY CENTER OF EXCELLENCE
* FDA SAYS UNDER PROJECT, FDA, AUSTRALIAN THERAPEUTIC GOODS ADMINISTRATION & HEALTH CANADA REVIEWED APPLICATIONS FOR 2 ONCOLOGY DRUGS
* FDA - UNDER PROJECT, FDA GRANTED ACCELERATED APPROVAL TO LENVIMA IN COMBINATION WITH KEYTRUDA FOR TREATMENT OF PATIENTS WITH ADVANCED ENDOMETRIAL CARCINOMA